Correlation between Ki67 and breast cancer prognosis
- PMID: 23364275
- DOI: 10.1159/000346475
Correlation between Ki67 and breast cancer prognosis
Abstract
Background: Ki67 is an immunohistochemical proliferation marker in many types of cancer and has been widely studied among breast cancer patients mostly through retrospective studies.
Methods: The MEDLINE/PubMed database was searched for publications with the medical subject heading 'Ki 67' and the key words 'breast', 'cancer', and 'prognosis'. We restricted our search to articles published until 2012.
Results: In this review, we included 78 articles and abstracts that were accessible and available in English. An effort to further explain the role of Ki67 in the prognosis of breast cancer has been made.
Conclusions: The debate on the prognostic role of Ki67 in breast cancer is still open, although most of the studies have established a relation between Ki67 and overall and disease-free survival. Further research should be made in order to establish Ki67 as a standard prognostic marker in breast cancer.
Copyright © 2013 S. Karger AG, Basel.
Similar articles
-
Prognostic value of Ki67 expression after short-term presurgical endocrine therapy for primary breast cancer.J Natl Cancer Inst. 2007 Jan 17;99(2):167-70. doi: 10.1093/jnci/djk020. J Natl Cancer Inst. 2007. PMID: 17228000
-
Topoisomerase II alpha expression and the Ki-67 labeling index correlate with prognostic factors in estrogen receptor-positive and human epidermal growth factor type-2-negative breast cancer.Breast Cancer. 2012 Oct;19(4):309-14. doi: 10.1007/s12282-011-0291-4. Epub 2011 Jul 2. Breast Cancer. 2012. PMID: 21725655
-
The prognostic value of apoptotic and proliferative markers in breast cancer.Breast Cancer Res Treat. 2013 Nov;142(2):323-39. doi: 10.1007/s10549-013-2748-y. Epub 2013 Nov 6. Breast Cancer Res Treat. 2013. PMID: 24194179
-
Ki67 and proliferation in breast cancer.J Clin Pathol. 2013 Jun;66(6):512-6. doi: 10.1136/jclinpath-2012-201085. Epub 2013 Feb 22. J Clin Pathol. 2013. PMID: 23436927 Review.
-
Ki67 in breast cancer: prognostic and predictive potential.Lancet Oncol. 2010 Feb;11(2):174-83. doi: 10.1016/S1470-2045(09)70262-1. Lancet Oncol. 2010. PMID: 20152769 Review.
Cited by
-
A high-resolution transcriptome map of cell cycle reveals novel connections between periodic genes and cancer.Cell Res. 2016 Aug;26(8):946-62. doi: 10.1038/cr.2016.84. Epub 2016 Jul 1. Cell Res. 2016. PMID: 27364684 Free PMC article.
-
Machine Learning techniques in breast cancer prognosis prediction: A primary evaluation.Cancer Med. 2020 May;9(9):3234-3243. doi: 10.1002/cam4.2811. Epub 2020 Mar 10. Cancer Med. 2020. PMID: 32154669 Free PMC article.
-
Phosphorylated ribosomal S6 (p-rpS6) as a post-treatment indicator of HER2 signalling targeted drug resistance.Biomarkers. 2015;20(5):313-22. doi: 10.3109/1354750X.2015.1068865. Biomarkers. 2015. PMID: 26329528 Free PMC article.
-
Comparison of CT- and MRI-Based Quantification of Tumor Heterogeneity and Vascularity for Correlations with Prognostic Biomarkers and Survival Outcomes: A Single-Center Prospective Cohort Study.Bioengineering (Basel). 2023 Apr 22;10(5):504. doi: 10.3390/bioengineering10050504. Bioengineering (Basel). 2023. PMID: 37237574 Free PMC article.
-
Correlation between the Expression of Topo IIα and Ki67 in breast cancer and its clinical Pathological characteristics.Pak J Med Sci. 2017 Jul-Aug;33(4):844-848. doi: 10.12669/pjms.334.13143. Pak J Med Sci. 2017. PMID: 29067051 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
